Ellevest, Inc. Ironwood Pharmaceuticals Inc Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$9.9 - $12.43 $396 - $497	40 New	40 $0
Q4 2021 Jan 24, 2022	SELL	$10.86 - $13.95 $412 - $530	-38 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$11.92 - $13.92 $381 - $445	32 Added 533.33%	38 $0
Q1 2021 May 03, 2021	SELL	$9.04 - $11.86 $488 - $640	-54 Reduced 90.0%	6 $0
Q4 2020 Feb 04, 2021	BUY	$9.05 - $12.2 $543 - $732	60 New	60 $1,000
Q2 2020 Jul 06, 2020	SELL	$9.14 - $11.97 $850 - $1,113	-93 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$8.22 - $14.0 $764 - $1,302	93 New	93 $1,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.